WO2024120767 - MODIFIED RNA POLYMERASE ACTIVITIES
National phase entry:
Publication Number
WO/2024/120767
Publication Date
13.06.2024
International Application No.
PCT/EP2023/081808
International Filing Date
15.11.2023
Title **
[English]
MODIFIED RNA POLYMERASE ACTIVITIES
[French]
ACTIVITÉS D'ARN POLYMÉRASE MODIFIÉ
Applicants **
NOVOZYMES A/S
Inventors
NAKANISHI, Takashi
Priority Data
22211463.9
05.12.2022
EP
23152649.2
20.01.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2318 | |
| EPO | Filing, Examination, Granting | 9160 | |
| Japan | Filing, Examination, Granting | 2201 | |
| South Korea | Filing, Examination, Granting | 2055 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
20,474
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to mutant host cells with reduced RNA polymerase subunit expression, polynucleotides and expression vectors for reduced expression of RNA polymerase subunit in a host cell, and host cells and methods for producing a polypeptide of interest.[French]
La présente invention concerne des cellules hôtes mutantes ayant une expression réduite de sous-unité d'ARN polymérase, des polynucléotides et des vecteurs d'expression pour une expression réduite de sous-unité d'ARN polymérase dans une cellule hôte, et des cellules hôtes et des procédés de production d'un polypeptide d'intérêt.